CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice · Shareholder rights changed · Bylaws or fiscal year change · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- D Other Notice of Sales of Unregistered Securities
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 74,150 shares (grant or award)
- 4 Grant or award CHIEF INNOVATION OFFICER acquired 24,717 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 98,866 shares (grant or award)
Page 5 of 53 · 1,057 filings